Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study

BACKGROUND: Increases in measured inulin clearance, measured creatinine clearance, and estimated glomerular filtration rate (eGFR) have been observed with bardoxolone methyl in 7 studies enrolling approximately 2,600 patients with type 2 diabetes (T2D) and chronic kidney disease (CKD). The largest o...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Nephrol
Päätekijät: Chin, Melanie P., Bakris, George L., Block, Geoffrey A., Chertow, Glenn M., Goldsberry, Angie, Inker, Lesley A., Heerspink, Hiddo J.L., O'Grady, Megan, Pergola, Pablo E., Wanner, Christoph, Warnock, David G., Meyer, Colin J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: S. Karger AG 2018
Aiheet:
Original Report: Patient-Oriented, Translational Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5841134/
https://ncbi.nlm.nih.gov/pubmed/29402767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000486398
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia